Lepore, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 1.763
EU - Europa 1.414
AS - Asia 1.333
SA - Sud America 281
AF - Africa 30
OC - Oceania 3
Totale 4.824
Nazione #
US - Stati Uniti d'America 1.713
SG - Singapore 596
DE - Germania 511
CN - Cina 284
BR - Brasile 222
SE - Svezia 199
VN - Vietnam 154
FR - Francia 140
IT - Italia 137
UA - Ucraina 94
GB - Regno Unito 81
FI - Finlandia 64
IN - India 62
IE - Irlanda 49
HK - Hong Kong 39
ID - Indonesia 38
JP - Giappone 38
RU - Federazione Russa 26
AR - Argentina 24
BD - Bangladesh 24
CA - Canada 20
MX - Messico 19
PL - Polonia 19
BE - Belgio 18
ES - Italia 17
TR - Turchia 16
IQ - Iraq 15
CO - Colombia 14
IR - Iran 12
NL - Olanda 12
KR - Corea 10
ZA - Sudafrica 10
PH - Filippine 9
AT - Austria 7
CZ - Repubblica Ceca 7
PT - Portogallo 6
SA - Arabia Saudita 6
TW - Taiwan 6
CL - Cile 5
DZ - Algeria 5
EC - Ecuador 5
TN - Tunisia 5
UZ - Uzbekistan 5
BY - Bielorussia 4
CH - Svizzera 4
GR - Grecia 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
VE - Venezuela 4
AU - Australia 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
EG - Egitto 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LU - Lussemburgo 1
MQ - Martinica 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.824
Città #
Singapore 312
Chandler 267
San Jose 172
Ashburn 155
Los Angeles 75
Beijing 59
Ann Arbor 56
New York 56
Jacksonville 55
Ho Chi Minh City 54
San Mateo 49
Dublin 46
Hanoi 42
Hefei 40
Marseille 39
Helsinki 36
Hong Kong 36
Tokyo 36
Milan 35
Lauterbourg 34
Jakarta 30
Munich 29
Nanjing 29
Boston 27
Dallas 25
Rome 24
The Dalles 23
Wilmington 22
Nanchang 21
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Frankfurt am Main 18
Brussels 17
Houston 17
Nürnberg 17
Council Bluffs 16
Moscow 16
São Paulo 16
Redmond 14
Seattle 14
Augusta 13
Santa Clara 13
Dhaka 12
Fairfield 12
Pune 11
Warsaw 11
Brooklyn 10
Kent 10
Seoul 10
Chennai 9
Lancaster 9
Lawrence 9
Orem 9
Paris 9
Andover 8
Atlanta 8
Buffalo 8
Da Nang 8
Izmir 8
London 8
Mexico City 8
Amsterdam 7
Bucaramanga 7
Denver 7
Düsseldorf 7
Madrid 7
Montreal 7
St Louis 7
Bremen 6
Detroit 6
Hebei 6
Lappeenranta 6
Leawood 6
Manchester 6
Poplar 6
Redwood City 6
Taichung 6
Turku 6
Boardman 5
Brno 5
Bắc Ninh 5
Hangzhou 5
Kish 5
Rio de Janeiro 5
Shanghai 5
Shenyang 5
Tashkent 5
University Park 5
Bogotá 4
Busto Arsizio 4
Fremont 4
Johannesburg 4
Kunming 4
Mumbai 4
Pescara 4
Roubaix 4
San Francisco 4
Tianjin 4
Totale 2.508
Nome #
Cortical visual function in preterm infants in the first year. 275
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 218
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 215
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 212
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 199
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 197
Early visual and neuro-development in preterm infants with and without retinopathy 172
An epidemiological analysis of retinopathy of prematurity over 10 years. 160
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 157
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 156
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 151
A cost effectiveness analysis of cataract surgery 147
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 135
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 133
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 132
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 123
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 122
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 122
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 113
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications 112
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 110
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 101
The role of retinal imaging in the management of abusive head trauma cases 101
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 91
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial 89
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 89
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next 86
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 81
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial 80
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 80
International Classification of Retinopathy of Prematurity, Third Edition 75
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 69
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial 64
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 62
Ranibizumab population pharmacokinetics and free vegf pharmacodynamics in preterm infants with retinopathy of prematurity in the rainbow trial 61
Early angiographic signs of retinopathy of prematurity requiring treatment 60
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial 59
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 59
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial 58
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis 58
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study 57
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity 52
Totale 4.893
Categoria #
all - tutte 18.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 51 6
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024289 20 75 23 11 5 57 14 3 5 19 36 21
2024/2025695 13 18 56 23 38 28 35 26 126 63 143 126
2025/20261.840 284 73 122 224 273 102 339 117 154 132 20 0
Totale 4.893